Zydus Cadila has received USFDA approval to market Mirtazapine orally disintegrating tablets, an anti depressant, in the US market. The drug will be marketed in strengths 15mg, 30mg and 45mg. The company will manufacture the product at its facility in Baddi. The Gujarat-based group has more than 115 approvals and has filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
Company Profile : Cadila Healthcare Ltd
Leave a Reply